Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 2
1983 3
1984 1
1986 1
1988 4
1989 1
1991 1
1992 1
1993 4
1994 2
1995 3
1996 2
1997 10
1998 5
1999 3
2000 2
2001 8
2002 9
2003 8
2004 7
2005 10
2006 5
2007 5
2008 7
2009 5
2010 9
2011 11
2012 3
2013 4
2014 6
2015 8
2016 10
2017 7
2018 7
2019 14
2020 10
2021 8
2022 4
2023 9
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

204 results

Results by year

Filters applied: . Clear all
Page 1
Hepatic Perfusion Therapy.
Rajeev R, Gamblin TC, Turaga KK. Rajeev R, et al. Surg Clin North Am. 2016 Apr;96(2):357-68. doi: 10.1016/j.suc.2015.12.005. Surg Clin North Am. 2016. PMID: 27017869 Review.
The procedure involves vascular isolation of the liver and delivery of chemotherapy via the hepatic artery and extraction from retrohepatic vena cava. Benefits of hepatic perfusion have been observed in hepatic metastases of ocular melanoma and colorectal can …
The procedure involves vascular isolation of the liver and delivery of chemotherapy via the hepatic artery and extraction from retrohepatic …
Worldwide Incidence of Ocular Melanoma and Correlation With Pigmentation-Related Risk Factors.
Wu M, Yavuzyigitoglu S, Brosens E, Ramdas WD, Kiliç E; Rotterdam Ocular Melanoma Study Group (ROMS). Wu M, et al. Invest Ophthalmol Vis Sci. 2023 Oct 3;64(13):45. doi: 10.1167/iovs.64.13.45. Invest Ophthalmol Vis Sci. 2023. PMID: 37902747 Free PMC article.
PURPOSE: The worldwide incidence of ocular melanoma (OM), uveal melanoma (UM), and conjunctival melanoma has last been reported on 15 years ago. Recently, light iris color and four specific single-nucleotide-polymorphisms (SNPs) have been identified as a UM-risk fac …
PURPOSE: The worldwide incidence of ocular melanoma (OM), uveal melanoma (UM), and conjunctival melanoma has last been reporte …
Incidence and survival of ocular melanoma in National Cancer Registry of Poland in 2010-2017.
Nowak MS, Romanowska-Dixon B, Grabska-Liberek I, Żurek M. Nowak MS, et al. Adv Clin Exp Med. 2022 Jun;31(6):615-621. doi: 10.17219/acem/146581. Adv Clin Exp Med. 2022. PMID: 35349230 Free article.
BACKGROUND: Oncology trends are based on data coming from different countries and ocular melanoma is the most common primary eye cancer in adults. OBJECTIVES: To investigate the incidence and characteristics of ocular melanoma in the overall population …
BACKGROUND: Oncology trends are based on data coming from different countries and ocular melanoma is the most common primary e …
Clinical features and survival outcomes of ocular melanoma in a multi-ethnic Asian cohort.
Tan LLY, Hong J, Goh WL, Chang EWY, Yang VS, Poon E, Somasundaram N, Farid M, Chan ASY, Chan JY. Tan LLY, et al. Sci Rep. 2020 Oct 1;10(1):16367. doi: 10.1038/s41598-020-73534-x. Sci Rep. 2020. PMID: 33004998 Free PMC article.
We conducted a retrospective review of patients (n = 44) with histologically-proven ocular melanoma within a multi-ethnic Asian cohort from Singapore. ...In conclusion, our study demonstrates the poor ocular melanoma outcomes in Southeast Asians, highl …
We conducted a retrospective review of patients (n = 44) with histologically-proven ocular melanoma within a multi-ethnic Asia …
Clinical spectrum, treatment and outcomes of uveal melanoma in a tertiary centre.
Wong W, Sundar G, Chee C, Zhao PS, Rajagopalan R, Gopal L. Wong W, et al. Singapore Med J. 2019 Sep;60(9):474-478. doi: 10.11622/smedj.2019054. Epub 2019 Jun 14. Singapore Med J. 2019. PMID: 31197380 Free PMC article.
Classification of choroidal melanoma as small, medium or large was based on the criteria established by the Collaborative Ocular Melanoma Study. RESULTS: Mean age at presentation was 42.9 (range 27-67) years. ...Treatment was enucleation in 5 (45.5%) patients, plaqu …
Classification of choroidal melanoma as small, medium or large was based on the criteria established by the Collaborative Ocular M …
Metastatic melanoma to the liver: a contemporary and comprehensive review of surgical, systemic, and regional therapeutic options.
Agarwala SS, Eggermont AM, O'Day S, Zager JS. Agarwala SS, et al. Cancer. 2014 Mar 15;120(6):781-9. doi: 10.1002/cncr.28480. Epub 2013 Dec 2. Cancer. 2014. PMID: 24301420 Free article. Review.
In contrast, no active systemic treatment has yet been identified for metastatic ocular melanoma. HIA and intravenous delivery of fotemustine have been compared in a randomized phase 3 trial in patients with unresectable metastases from melanoma, but no differences …
In contrast, no active systemic treatment has yet been identified for metastatic ocular melanoma. HIA and intravenous delivery …
Modelling uveal melanoma.
Foss AJ, Cree IA, Dolin PJ, Hungerford JL. Foss AJ, et al. Br J Ophthalmol. 1999 May;83(5):588-94. doi: 10.1136/bjo.83.5.588. Br J Ophthalmol. 1999. PMID: 10216060 Free PMC article.
CONCLUSIONS: There is significant underreporting or underdiagnosis of ocular melanoma for England and Wales in those over the age of 65 years. In those under the age of 65, a model is presented for ocular melanoma oncogenesis requiring three rate limit …
CONCLUSIONS: There is significant underreporting or underdiagnosis of ocular melanoma for England and Wales in those over the …
A pilot study of bevacizumab and interferon-alpha2b in ocular melanoma.
Guenterberg KD, Grignol VP, Relekar KV, Varker KA, Chen HX, Kendra KL, Olencki TE, Carson WE 3rd. Guenterberg KD, et al. Am J Clin Oncol. 2011 Feb;34(1):87-91. doi: 10.1097/COC.0b013e3181d2ed67. Am J Clin Oncol. 2011. PMID: 20458209 Free PMC article. Clinical Trial.
OBJECTIVES: We hypothesized that administration of bevacizumab, a monoclonal antibody that neutralizes vascular endothelial growth factor, in combination with high-dose interferon-alpha2b (IFN-alpha2b), an inhibitor of basic fibroblast growth factor, would have clinical activity …
OBJECTIVES: We hypothesized that administration of bevacizumab, a monoclonal antibody that neutralizes vascular endothelial growth factor, i …
The Collaborative Ocular Melanoma Study: an overview.
Margo CE. Margo CE. Cancer Control. 2004 Sep-Oct;11(5):304-9. doi: 10.1177/107327480401100504. Cancer Control. 2004. PMID: 15377989 Free article. Review.
BACKGROUND: The Collaborative Ocular Melanoma Study (COMS) is a 3-arm study that includes two multicenter randomized clinical trials designed to compare the effectiveness of brachytherapy to enucleation for treatment of medium-size choroidal melanomas, and the effec …
BACKGROUND: The Collaborative Ocular Melanoma Study (COMS) is a 3-arm study that includes two multicenter randomized clinical …
Ocular Brachytherapy (Interventional Radiotherapy): Preserving the Vision.
Fionda B, Pagliara MM, Chyrek AJ, Guix B, O'Day RFJ, Fog LS, Martínez-Monge R, Tagliaferri L. Fionda B, et al. Clin Oncol (R Coll Radiol). 2023 Aug;35(8):e445-e452. doi: 10.1016/j.clon.2023.01.021. Epub 2023 Feb 6. Clin Oncol (R Coll Radiol). 2023. PMID: 36792447
Brachytherapy (interventional radiotherapy; IRT) has a great advantage, when compared with enucleation, both in terms of organ and function sparing. The Collaborative Ocular Melanoma Study introduced into clinical practice a standardised procedure that allowed the e …
Brachytherapy (interventional radiotherapy; IRT) has a great advantage, when compared with enucleation, both in terms of organ and function …
204 results